T-bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine
How transcription factor T-bet and Th17 cells contribute to colitis remains incompletely understood. Here the authors identify T-bet as a negative regulator of IL-23R pathway activation and show that T-bet deficient T cells drive colitogenic Th17 responses dependent on the cytokines IL-17A and IL-22...
Guardado en:
Autores principales: | Thomas Krausgruber, Chris Schiering, Krista Adelmann, Oliver J. Harrison, Agnieszka Chomka, Claire Pearson, Philip P. Ahern, Matthew Shale, Mohamed Oukka, Fiona Powrie |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7468206667654e0d9f30482bda325b7b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alpha kinase 1 controls intestinal inflammation by suppressing the IL-12/Th1 axis
por: Grigory Ryzhakov, et al.
Publicado: (2018) -
“Betting on nature” or “betting on others”: anti-coordination induces uniquely high levels of entropy
por: Gabriele Chierchia, et al.
Publicado: (2018) -
IL-23 receptor deficiency results in lower bone mass via indirect regulation of bone formation
por: Wida Razawy, et al.
Publicado: (2021) -
IL-21 drives expansion and plasma cell differentiation of autoreactive CD11chiT-bet+ B cells in SLE
por: Shu Wang, et al.
Publicado: (2018) -
T-bet syndrome-associated bronchial asthma phenotype
por: L. N. Sorokina, et al.
Publicado: (2020)